Sfoglia per Titolo
Phase I-II induction intensified regimens including fludarabine or mylotarg for acute myeloid leukaemia patients: comparison by response and follow-up.
2009-01-01 Papayannidis, C.; Candoni, A.; Paolini, S.; Ottaviani, E.; Iacobucci, I.; Rondoni, M.; Malagola, Michele; Piccaluga, P. p.; Cilloni, D.; Fanin, R.; Visani, G.; Baccarani, M.; Russo, Domenico; Martinelli, G. .
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments
2012-01-01 Scorsetti, M.; Alongi, F.; Fogliata, A.; Pentimalli, S.; Navarria, P.; Lobefalo, F.; Garcia-Etienne, C.; Clivio, A.; Cozzi, L.; Mancosu, P.; Nicolini, G.; Vanetti, E.; Eboli, M.; Rossetti, C.; Rubino, A.; Sagona, A.; Arcangeli, S.; Gatzemeier, W.; Masci, G.; Torrisi, R.; Testori, A.; Alloisio, M.; Santoro, A.; Tinterri, C.
Phase I-II Study of Hypofractionated Simultaneous Integrated Boost With Tomotherapy for Prostate Cancer
2009-01-01 Di Muzio, N.; Fiorino, C.; Cozzarini, C.; Alongi, F.; Broggi, S.; Mangili, P.; Guazzoni, G.; Valdagni, R.; Calandrino, R.; Fazio, F.
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition
2010-01-01 Barosi, G; Gattoni, E; Guglielmelli, P; Campanelli, R; Facchetti, Fabio; Fisogni, S; Goldberg, J; Marchioli, R; Hoffman, R; Vannucchi, Am
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers
2016-01-01 Roviello, Giandomenico; Milani, Manuela; Gobbi, Angela; Cappelletti, Maria Rosa; Zanotti, Laura; Senti, Chiara; Bottini, Alberto; Strina, Carla; Sigala, Sandra; Generali, Daniele
Phase II Multicentric Explorative Study of Intermittent Imatinib (IM) Treatment (INTERIM) in Elderly Patients with Ph+ Chronic Myeloid Leukemia (CML) Who Achieved a Stable Complete Cytogenetic Response (CCgR) with Standard IM Therapy.
2009-01-01 Russo, Domenico; Gianantonio, Rosti; Giovanni, Martinelli; Malagola, Michele; Salvatore, Mirto; Diamante, Turri; Marco, Gobbi; Ivana, Pierri; Umberto, Vitolo; Patrizia, Pregno; Francesco Di, Raimondo; Fabio, Stagno; Robin, Foà; Giuliana, Alimena; Massimo, Breccia; Francesco, Nobile; Bruno, Martino; Alessandro, Rambaldi; Tamara, Intermesoli; Giuseppe, Saglio; Giovanna Rege, Cambrin; Giuseppe, Visani; Giuseppina, Nicolini; Paolo de, Fabritiis; Elisabetta, Abruzzese; Renato, Fanin; Mario, Tiribelli; Piero, Galieni; Catia, Bigazzi; Vincenzo, Liso; Giorgina, Specchia; Emanuele, Angelucci; Emilio, Usala; Caterina, Musolino; Sabina, Russo; Gianluca, Gaidano; Monia, Lunghi; Francesco, Lauria; Monica, Bocchia; Francesco, Rodeghiero; Anna, D'Emilio; Giovanni, Quarta; Mariella, Girasoli; Alberto, Bosi; Valeria, Santini; Giuseppe, Fioritoni; Roberto Di, Lorenzo; Chiara, Colombi; Miriam, Fogli; Marilina, Amabile; Nicoletta, Testoni; Antonio De, Vivo; Michele, Baccarani
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
2009-01-01 Pecorelli, Sergio; Ray Coquard, I; Tredan, O; Colombo, N; Parma, G; Tisi, G; Katsaròs, D; Lhommé, C; Lissoni, Aa; Vermorken, Jb; du Bois, A; Poveda, A; Frigerio, L; Barbieri, P; Carminati, P; Brienza, S; Guastalla, J. P.
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes.
2010-01-01 Pecorelli, Sergio; Ray Coquard, I; Tredan, O; Colombo, N; Parma, G; Tisi, G; Katsaròs, D; Lhommé, C; Lissoni, Aa; Vermorken, Jb; du Bois, A; Poveda, A; Frigerio, L; Barbieri, P; Carminati, P; Brienza, S; Guastalla, J. P.
Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years.
2008-01-01 Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R.
Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer
2018-01-01 Alongi, Filippo; Mazzola, Rosario; Fiorentino, Alba; Corradini, Stefanie; Aiello, Dario; Figlia, Vanessa; Gregucci, Fabiana; Ballario, Riccardo; Cavalleri, Stefano; Ruggieri, Ruggero
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)
1989-01-01 Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S.
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma
2022-01-01 Lagana, M.; Grisanti, S.; Ambrosini, R.; Cosentini, D.; Abate, A.; Zamparini, M.; Ferrari, V. D.; Gianoncelli, A.; Turla, A.; Canu, L.; Terzolo, M.; Tiberio, G. A. M.; Sigala, S.; Berruti, A.
Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
2019-01-01 Mesia, R.; Bossi, P.; Hansen, A. R.; Hsieh, C. -Y.; Licitra, L. F.; Tan, E. -H.; Chen, P.; Miller, J.; Siu, L. L.; Haddad, R. I.
A PHASE II STUDY OF LIPOSOMAL DOXORUBICIN IN RECURRENT EPITHELIAL OVARIAN CARCINOMA.
2004-01-01 Arcuri, C; Sorio, R; Tognon, G; Gambino, Angela; Scalone, S; Lucenti, A; Caffo, O; Valduga, F; Arisi, E; Galligioni, E.
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
2014-01-01 Guidetti, Anna; Carlo Stella, Carmelo; Locatelli, Silvia L.; Malorni, Walter; Mortarini, Roberta; Viviani, Simonetta; Russo, Domenico; Marchianò, Alfonso; Sorasio, Roberto; Dodero, Anna; Farina, Lucia; Giordano, Laura; Di Nicola, Massimo; Anichini, Andrea; Corradini, Paolo; Gianni, Alessandro M.
Phase II study of preoperative TPF chemotherapy in molecularly selected resectable oral cavity cancer-Trial in progress
2015-01-01 Bianchi, R; Bossi, P; Pistillo, P; Locati, L; Licitra, L
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG)
2010-01-01 Grisanti, Salvatore; R., Pedersini; Vd, Ferrari; R., Liserre; F., Consoli; Poliani, Pietro Luigi; BUGLIONE DI MONALE E BASTIA, Michela; G., Rangoni; E., Montini; E., Simoncini
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines
2000-01-01 Berruti, Alfredo; Sperone, P; Bottini, A; Gorzegno, G; Lorusso, V; Brunelli, A; Botta, M; Tampellini, M; Donadio, M; Mancarella, S; DE LENA, M; Alquati, P; Dogliotti, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase I-II induction intensified regimens including fludarabine or mylotarg for acute myeloid leukaemia patients: comparison by response and follow-up. | 1-gen-2009 | Papayannidis, C.; Candoni, A.; Paolini, S.; Ottaviani, E.; Iacobucci, I.; Rondoni, M.; Malagola, Michele; Piccaluga, P. p.; Cilloni, D.; Fanin, R.; Visani, G.; Baccarani, M.; Russo, Domenico; Martinelli, G. . | |
| Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments | 1-gen-2012 | Scorsetti, M.; Alongi, F.; Fogliata, A.; Pentimalli, S.; Navarria, P.; Lobefalo, F.; Garcia-Etienne, C.; Clivio, A.; Cozzi, L.; Mancosu, P.; Nicolini, G.; Vanetti, E.; Eboli, M.; Rossetti, C.; Rubino, A.; Sagona, A.; Arcangeli, S.; Gatzemeier, W.; Masci, G.; Torrisi, R.; Testori, A.; Alloisio, M.; Santoro, A.; Tinterri, C. | |
| Phase I-II Study of Hypofractionated Simultaneous Integrated Boost With Tomotherapy for Prostate Cancer | 1-gen-2009 | Di Muzio, N.; Fiorino, C.; Cozzarini, C.; Alongi, F.; Broggi, S.; Mangili, P.; Guazzoni, G.; Valdagni, R.; Calandrino, R.; Fazio, F. | |
| Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition | 1-gen-2010 | Barosi, G; Gattoni, E; Guglielmelli, P; Campanelli, R; Facchetti, Fabio; Fisogni, S; Goldberg, J; Marchioli, R; Hoffman, R; Vannucchi, Am | |
| A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers | 1-gen-2016 | Roviello, Giandomenico; Milani, Manuela; Gobbi, Angela; Cappelletti, Maria Rosa; Zanotti, Laura; Senti, Chiara; Bottini, Alberto; Strina, Carla; Sigala, Sandra; Generali, Daniele | |
| Phase II Multicentric Explorative Study of Intermittent Imatinib (IM) Treatment (INTERIM) in Elderly Patients with Ph+ Chronic Myeloid Leukemia (CML) Who Achieved a Stable Complete Cytogenetic Response (CCgR) with Standard IM Therapy. | 1-gen-2009 | Russo, Domenico; Gianantonio, Rosti; Giovanni, Martinelli; Malagola, Michele; Salvatore, Mirto; Diamante, Turri; Marco, Gobbi; Ivana, Pierri; Umberto, Vitolo; Patrizia, Pregno; Francesco Di, Raimondo; Fabio, Stagno; Robin, Foà; Giuliana, Alimena; Massimo, Breccia; Francesco, Nobile; Bruno, Martino; Alessandro, Rambaldi; Tamara, Intermesoli; Giuseppe, Saglio; Giovanna Rege, Cambrin; Giuseppe, Visani; Giuseppina, Nicolini; Paolo de, Fabritiis; Elisabetta, Abruzzese; Renato, Fanin; Mario, Tiribelli; Piero, Galieni; Catia, Bigazzi; Vincenzo, Liso; Giorgina, Specchia; Emanuele, Angelucci; Emilio, Usala; Caterina, Musolino; Sabina, Russo; Gianluca, Gaidano; Monia, Lunghi; Francesco, Lauria; Monica, Bocchia; Francesco, Rodeghiero; Anna, D'Emilio; Giovanni, Quarta; Mariella, Girasoli; Alberto, Bosi; Valeria, Santini; Giuseppe, Fioritoni; Roberto Di, Lorenzo; Chiara, Colombi; Miriam, Fogli; Marilina, Amabile; Nicoletta, Testoni; Antonio De, Vivo; Michele, Baccarani | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. | 1-gen-2009 | Pecorelli, Sergio; Ray Coquard, I; Tredan, O; Colombo, N; Parma, G; Tisi, G; Katsaròs, D; Lhommé, C; Lissoni, Aa; Vermorken, Jb; du Bois, A; Poveda, A; Frigerio, L; Barbieri, P; Carminati, P; Brienza, S; Guastalla, J. P. | |
| Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. | 1-gen-2010 | Pecorelli, Sergio; Ray Coquard, I; Tredan, O; Colombo, N; Parma, G; Tisi, G; Katsaròs, D; Lhommé, C; Lissoni, Aa; Vermorken, Jb; du Bois, A; Poveda, A; Frigerio, L; Barbieri, P; Carminati, P; Brienza, S; Guastalla, J. P. | |
| Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years. | 1-gen-2008 | Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R. | |
| Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer | 1-gen-2018 | Alongi, Filippo; Mazzola, Rosario; Fiorentino, Alba; Corradini, Stefanie; Aiello, Dario; Figlia, Vanessa; Gregucci, Fabiana; Ballario, Riccardo; Cavalleri, Stefano; Ruggieri, Ruggero | |
| Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL) | 1-gen-1989 | Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S. | |
| Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma | 1-gen-2022 | Lagana, M.; Grisanti, S.; Ambrosini, R.; Cosentini, D.; Abate, A.; Zamparini, M.; Ferrari, V. D.; Gianoncelli, A.; Turla, A.; Canu, L.; Terzolo, M.; Tiberio, G. A. M.; Sigala, S.; Berruti, A. | |
| Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma | 1-gen-2019 | Mesia, R.; Bossi, P.; Hansen, A. R.; Hsieh, C. -Y.; Licitra, L. F.; Tan, E. -H.; Chen, P.; Miller, J.; Siu, L. L.; Haddad, R. I. | |
| A PHASE II STUDY OF LIPOSOMAL DOXORUBICIN IN RECURRENT EPITHELIAL OVARIAN CARCINOMA. | 1-gen-2004 | Arcuri, C; Sorio, R; Tognon, G; Gambino, Angela; Scalone, S; Lucenti, A; Caffo, O; Valduga, F; Arisi, E; Galligioni, E. | |
| Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases | 1-gen-2014 | Guidetti, Anna; Carlo Stella, Carmelo; Locatelli, Silvia L.; Malorni, Walter; Mortarini, Roberta; Viviani, Simonetta; Russo, Domenico; Marchianò, Alfonso; Sorasio, Roberto; Dodero, Anna; Farina, Lucia; Giordano, Laura; Di Nicola, Massimo; Anichini, Andrea; Corradini, Paolo; Gianni, Alessandro M. | |
| Phase II study of preoperative TPF chemotherapy in molecularly selected resectable oral cavity cancer-Trial in progress | 1-gen-2015 | Bianchi, R; Bossi, P; Pistillo, P; Locati, L; Licitra, L | |
| Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) | 1-gen-2010 | Grisanti, Salvatore; R., Pedersini; Vd, Ferrari; R., Liserre; F., Consoli; Poliani, Pietro Luigi; BUGLIONE DI MONALE E BASTIA, Michela; G., Rangoni; E., Montini; E., Simoncini | |
| Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines | 1-gen-2000 | Berruti, Alfredo; Sperone, P; Bottini, A; Gorzegno, G; Lorusso, V; Brunelli, A; Botta, M; Tampellini, M; Donadio, M; Mancarella, S; DE LENA, M; Alquati, P; Dogliotti, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile